Inozyme Pharma, Inc.
Records under this name other than patents Inozyme Pharma, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,846,603 | NPP1 Fusion Proteins now held by Biomarin Pharmaceutical Inc. In force · High confidence | In force | High confidence | |
| US 9,540,621 | NPP1 Fusion Proteins now held by Biomarin Pharmaceutical Inc. In force · Medium confidence | In force | Medium confidence | |
| US RE49,529 | Methods of Treating Tissue Calcification now held by Biomarin Pharmaceutical Inc. In force · Low confidence | In force | Low confidence | |
| US 11,364,284 | Methods of Treating Myointimal Proliferation now held by Biomarin Pharmaceutical Inc. In force · High confidence | In force | High confidence | |
| US 12,134,790 | Methods of Improving Cardiovascular Function and Treating Cardiovascular Disease Using a Recombinant Ectonucleotide Pyrophosphatase Phosphodiesterase (NPP1) now held by Biomarin Pharmaceutical Inc. In force · High confidence | In force | High confidence | |
| US 12,698,487 | Soluble ENPP1 Proteins and Uses Thereof now held by Biomarin Pharmaceutical Inc. In force · Medium confidence | In force | Medium confidence | |
| US 10,493,135 | Methods of Treating Tissue Calcification now held by Biomarin Pharmaceutical Inc. Surrendered on reissue Surrendered on reissue May 16, 2023 · Medium confidence | Surrendered on reissue | Surrendered on reissue May 16, 2023 | Medium confidence |
| 15/417,590 | NPP1 Fusion Proteins now held by Biomarin Pharmaceutical Inc. Abandoned Abandoned Dec 29, 2020 | Abandoned | Abandoned Dec 29, 2020 | |
| 17/105,245 | NPP1 Fusion Proteins now held by Biomarin Pharmaceutical Inc. Abandoned Abandoned Nov 17, 2022 | Abandoned | Abandoned Nov 17, 2022 | |
| 17/178,127 | Treatment of Diseases Involving Deficiency of ENPP1 or ENPP3 now held by Biomarin Pharmaceutical Inc. Abandoned Abandoned Sep 26, 2022 | Abandoned | Abandoned Sep 26, 2022 |